爱德华兹(EW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EW 爱德华兹

休市中 05-03 16:00:00 EDT

85.25

+0.19

+0.22%

盘后85.25

+0.000.00%

17:35 EDT

最高86.95	最低85.20	成交量232.72万
今开85.85	昨收85.06	日振幅2.06%
总市值513.72亿	流通市值508.61亿	总股本6.03亿
成交额1.99亿	换手率0.39%	流通股本5.97亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EW","market":"US","secType":"STK","nameCN":"爱德华兹","latestPrice":85.25,"timestamp":1714766400000,"preClose":85.06,"halted":0,"volume":2327197,"hourTrading":{"tag":"盘后","latestPrice":85.25,"preClose":85.25,"latestTime":"17:35 EDT","volume":510879,"amount":43552440.995,"timestamp":1714772151419},"delay":0,"floatShares":596614976,"shares":602600000,"eps":2.320049,"marketStatus":"休市中","marketStatusCode":7,"change":0.19,"latestTime":"05-03 16:00:00 EDT","open":85.85,"high":86.95,"low":85.2,"amount":199168524.12297,"amplitude":0.020574,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.320049,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"adjPreClose":85.06,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":85.54,"preClose":85.06,"latestTime":"09:18 EDT","volume":94,"amount":8039.63059,"timestamp":1714742310504},"postHourTrading":{"tag":"盘后","latestPrice":85.25,"preClose":85.25,"latestTime":"17:35 EDT","volume":510879,"amount":43552440.995,"timestamp":1714772151419},"volumeRatio":0.7401432250837519},"requestUrl":"/m/hq/s/EW/","defaultTab":"news","newsList":[{"id":"2431067325","title":"爱德华生命科学2024财年第一财季实现净利润3.52亿美元，同比增加3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431067325","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431067325?lang=zh_cn&edition=full","pubTime":"2024-04-29 00:25","pubTimestamp":1714321550,"startTime":"0","endTime":"0","summary":"3月31日，爱德华生命科学公布财报，公告显示公司2024财年第一财季净利润为3.52亿美元，同比增加3.23%；其中营业收入为15.98亿美元，同比增加9.45%，每股基本收益为0.58美元。从资产负债表来看，爱德华生命科学总负债25.50亿美元，其中短期债务24.80百万美元，资产负债比为3.82，流动比率为3.76。机构评级：截至2024年3月31日，当前有28家机构对爱德华生命科学目标价做出预测，其中目标均价为95.91美元，其中最低目标价为72.00美元，最高目标价为105.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042900255787bb778b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042900255787bb778b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430664206","title":"Piper Sandler：维持Edwards Lifesciences(EW.US)评级，由中性调整至中性评级, 目标价由85.00美元调整至88.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430664206","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430664206?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:36","pubTimestamp":1714142195,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Edwards Lifesciences(EW.US)评级，由中性调整至中性评级, 目标价由85.00美元调整至88.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622363887b42110&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622363887b42110&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430216245","title":"Edwards Lifesciences(EW.US)：2024年Q1财报实现营收15.98亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430216245","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430216245?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:12","pubTimestamp":1714108354,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences(EW.US)：2024年Q1财报实现营收15.98亿美元，前值为14.6亿美元，预期值为15.7亿美元；每股收益为0.66美元，前值为0.62美元，预期值为0.64美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261327178b55abd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261327178b55abd3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430262525","title":"爱德华生命科学公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2430262525","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430262525?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:35","pubTimestamp":1714091748,"startTime":"0","endTime":"0","summary":"   * 爱德华生命科学公司公布的截至 3 月份的季度调整后每股收益为 66 美分，高于去年同期的每股收益 62 美分。27位分析师对该季度的平均预期是每股收益64美分。华尔街预期为每股收益 63 美分至 66 美分。* 爱德华生命科学公司公布的本季度每股收益为 58 美分。* 公司报告的季度净收入为 3.519 亿美元。* Edwards Lifesciences Corp 的股价本季度下跌了 7.3%，今年迄今为止上涨了 16.2%。华尔街对 Edwards Lifesciences Corp 的 12 个月目标价中位数为 97.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430268784","title":"Edwards Lifesciences 第一季度利润超出预期，得益于心脏设备的强劲表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2430268784","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430268784?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:21","pubTimestamp":1714083679,"startTime":"0","endTime":"0","summary":"    路透社4月25日 - 爱德华生命科学公司周四公布，由于对其人工心脏瓣膜和其他医疗设备的需求强劲，该公司第一季度利润喜人。Edwards公司生产经导管主动脉瓣置换 设备，与雅培实验室  、波士顿科学  和美敦力  展开竞争。Edwards 第一季度的 TAVR 设备销售额增长了 6%，达到 10 亿美元，收入为 16 亿美元，超过了分析师预计的 15.7 亿美元。根据 LSEG 数据，调整后公司每股利润为 66 美分，高于分析师平均预期的 64 美分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430462500","title":"未来一天的看点 - 4月25日星期四","url":"https://stock-news.laohu8.com/highlight/detail?id=2430462500","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430462500?lang=zh_cn&edition=full","pubTime":"2024-04-25 02:30","pubTimestamp":1713983434,"startTime":"0","endTime":"0","summary":"美国劳工部的每周失业救济申请数据可能会显示，在截至4月20日的一周内，各州首次申请失业救济的人数增加了3000人，经季节性因素调整后为215000人。与此同时，首次领取失业救济金的人数可能从截至4月13日当周的181.2万人降至180.5万人。美国航空公司将公布第一季度财报。由于主要市场需求低迷，陶氏预计将公布第一季度收入下降的报告。烟草巨头 Altria 将公布第一季度业绩。受客户转向广告流媒体的帮助，Roku 第一季度收入预计将增长 14.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429140081","title":"爱德华生命科学公司  预计每股收益64美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2429140081","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429140081?lang=zh_cn&edition=full","pubTime":"2024-04-24 05:21","pubTimestamp":1713907299,"startTime":"0","endTime":"0","summary":"   * 爱德华生命科学公司将于4月25日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* LSEG分析师对爱德华生命科学公司的平均预期为每股收益64美分。该公司 2024 年 2 月 6 日发布的截至 3 月 31 日的每股收益指导值为 0.62 美元至 0.66 美元。* 华尔街对 Edwards Lifesciences Corp 的 12 个月目标价中位数为 97.00 美元，高于其上次收盘价 87.75 美元。4月23日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429223141","title":"媒体-EW 斯克里普斯探索出售黑人文化广播网 Bounce TV - CNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2429223141","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429223141?lang=zh_cn&edition=full","pubTime":"2024-04-24 03:56","pubTimestamp":1713902173,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月23日 - -- 来源链接：  -- 注：路透社未核实此报道，不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426407119","title":"BUZZ-斯蒂芬斯恢复对 UPS 和联邦快递的覆盖，分别给予 \"EW \"和 \"OW \"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2426407119","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426407119?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:23","pubTimestamp":1712676215,"startTime":"0","endTime":"0","summary":"    4月9日 - ** 斯蒂芬斯恢复对包裹递送公司联合包裹服务公司  和联邦快递  的评级，分别为 \"等权重 \"和 \"增持\"。** UPS 股价上涨 0.3%，而 FDX 下跌 0.4** 31 家券商中有 12 家将 UPS 评为 \"买入 \"或更高评级，17 家为 \"持有\"，2 家为 \"卖出\"；他们的 PT 中值为 159 美元** 32 家券商中有 22 家将 FDX 评为 \"买入 \"或更高评级，8 家为 \"持有\"，2 家为 \"卖出\"；其预测中值为 320 美元。** 今年以来，UPS 下降 4.4%；FDX 上升 8.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2425301369","title":"美国研究综述-康菲石油、Fastly、活力能源","url":"https://stock-news.laohu8.com/highlight/detail?id=2425301369","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2425301369?lang=zh_cn&edition=full","pubTime":"2024-04-08 15:13","pubTimestamp":1712560397,"startTime":"0","endTime":"0","summary":"    路透社4月8日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括康菲石油、Fastly 和 Vital Energy。要闻             * 康菲石油  ：Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。* Fastly Inc   ：Piper Sandler将其评级从 \"中性 \"上调至 \"增持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420171750","title":"NBA西部卡位战，约基奇35+16助掘金险胜森林狼","url":"https://stock-news.laohu8.com/highlight/detail?id=2420171750","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2420171750?lang=zh_cn&edition=full","pubTime":"2024-03-20 11:43","pubTimestamp":1710906220,"startTime":"0","endTime":"0","summary":"新京报讯 3月20日，NBA常规赛一场焦点战，掘金客场115比112险胜森林狼。目前，掘金比森林狼多赢一场，排名西部第二。易边后，森林狼在爱德华兹带领下，打出得分高潮，一度反超比分。最终，掘金拿下关键卡位战胜利。森林狼方面，爱德华兹30分8个篮板8次助攻，麦克丹尼尔斯26分6个篮板，李凯尔12分3个篮板4次助攻，康利13分6个篮板5次助攻。掘金方面，约基奇35分16个篮板，戈登14分11个篮板，波特26分，穆雷18分11次助攻。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320114427879b05eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320114427879b05eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419936871","title":"华尔街预测者齐弃衰退论 爱德华兹警告：自满情绪或重现2007年危机","url":"https://stock-news.laohu8.com/highlight/detail?id=2419936871","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2419936871?lang=zh_cn&edition=full","pubTime":"2024-03-15 02:10","pubTimestamp":1710439845,"startTime":"0","endTime":"0","summary":"华尔街的经济预测者们近期几乎一致地放弃了经济衰退的预测，这一转变与仅一年前他们普遍认为经济衰退几乎必然发生的观点形成鲜明对比。然而，爱德华兹警告说，其他更模糊的读数正在发出更令人担忧的信息。爱德华兹发现当前的自满情绪与2007年全球金融危机爆发前的情景有着惊人的相似之处。美国个人投资者协会最新的民意调查显示超过一半的受访者上周持乐观态度，该组织称这一数字“异常之高”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/03/15021039858450.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2417793177","title":"爱德华生命科学盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417793177","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417793177?lang=zh_cn&edition=full","pubTime":"2024-03-07 23:26","pubTimestamp":1709825209,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日23时26分，爱德华生命科学股票出现异动，股价急速拉升5.02%。截至发稿，该股报92.76美元/股，成交量156.531万股，换手率0.26%，振幅2.15%。爱德华生命科学股票所在的医疗器械行业中，整体涨幅为1.01%。爱德华生命科学公司简介：爱德华兹生命科学公司于2000年从百特国际公司中分离出来，设计、制造及推销一系列用于晚期结构性心脏病的医疗设备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072326507a4a81fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403072326507a4a81fb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416524706","title":"迈入百亿市场！爱德华生命科学三尖瓣Evoque获批，健世科技紧随其后，2030年市场潜力爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2416524706","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2416524706?lang=zh_cn&edition=full","pubTime":"2024-03-01 13:03","pubTimestamp":1709269391,"startTime":"0","endTime":"0","summary":"和讯为您带来最新券商看点，供您参考：看点一： 爱德华生命科学的三尖瓣产品Evoque获得美国FDA批准，这是首个获批的经导管三尖瓣置换产品。预计将推动公司业绩增长，海外市场规模有望在2030年达到136.06亿美元。看点二： 在国内市场，健世科技的三尖瓣介入产品LuX-Valve系列处于NMPA审批阶段，有望在2024年成为国内首款获批产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403011334588af41eeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403011334588af41eeb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410374195","title":"爱德华生命科学2023财年实现净利润14.02亿美元，同比减少7.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410374195","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410374195?lang=zh_cn&edition=full","pubTime":"2024-02-09 00:26","pubTimestamp":1707409596,"startTime":"0","endTime":"0","summary":"12月31日，爱德华生命科学公布财报，公告显示公司2023财年净利润为14.02亿美元，同比减少7.88%；其中营业收入为60.05亿美元，同比增加11.58%，每股基本收益为2.31美元。从资产负债表来看，爱德华生命科学总负债26.44亿美元，其中短期债务24.90百万美元，资产负债比为3.55，流动比率为3.38。机构评级：截至2023年12月31日，当前有26家机构对爱德华生命科学目标价做出预测，其中目标均价为91.77美元，其中最低目标价为72.00美元，最高目标价为105.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209002648817a8532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209002648817a8532&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409220507","title":"爱德华生命科学盘中异动 急速下跌6.32%报82.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409220507","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409220507?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:35","pubTimestamp":1707316522,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日22时35分，爱德华生命科学股票出现波动，股价大幅下跌6.32%。截至发稿，该股报82.67美元/股，成交量37.3616万股，换手率0.06%，振幅4.41%。爱德华生命科学股票所在的医疗器械行业中，整体跌幅为0.16%。爱德华生命科学公司简介：爱德华兹生命科学公司于2000年从百特国际公司中分离出来，设计、制造及推销一系列用于晚期结构性心脏病的医疗设备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240207223522861d4030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240207223522861d4030&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409787222","title":"BUZZ-爱德华兹预计第一季度利润大幅低于预期后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2409787222","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409787222?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:16","pubTimestamp":1707315402,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    2月7日 - ** 医疗设备制造商爱德华生命科学  股价盘前下跌1.3%至87.14美元** 该公司预计 (link) 2024 年第一季度利润介于 62 美分和 66 美分之间，中间值低于分析师平均预期的 66 美分。** 公司重申全年利润和总收入预期** 第四季度利润符合分析师预期 - LSEG 数据** 截至上次收盘，股价在过去 12 个月中上涨了约 12","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409216232","title":"美国研究综述-皇冠控股公司、沃特斯公司、西部制药服务公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2409216232","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409216232?lang=zh_cn&edition=full","pubTime":"2024-02-07 15:56","pubTimestamp":1707292591,"startTime":"0","endTime":"0","summary":"    路透2月7日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括空气产品和皇冠控股公司、沃特斯公司和西部制药服务公司。* 沃特斯公司  ：Evercore ISI将目标价从315美元上调至320美元             * West Pharmaceutical Services Inc   ：杰富瑞将目标价从 \"持有 \"上调至 \"买入 以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409125196","title":"爱德华生命科学公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2409125196","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409125196?lang=zh_cn&edition=full","pubTime":"2024-02-07 08:43","pubTimestamp":1707266611,"startTime":"0","endTime":"0","summary":"   * 爱德华生命科学公司  公布的截至12月底的季度调整后每股收益为64美分，与去年同期持平。华尔街预期为每股收益 62 美分至 67 美分。* 爱德华生命科学公司公布的本季度每股收益为61美分。* 公司报告的季度净收入为 3.699 亿美元。* Edwards Lifesciences Corp 的股价本季度上涨了 12.9%。华尔街对 Edwards Lifesciences Corp 的 12 个月目标价中位数为 84.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409230179","title":"心脏设备销售强劲，Edwards Lifesciences 季度业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2409230179","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409230179?lang=zh_cn&edition=full","pubTime":"2024-02-07 06:42","pubTimestamp":1707259322,"startTime":"0","endTime":"0","summary":"    路透2月6日 - 爱德华生命科学公司周二公布的第四季度利润超过了华尔街的预期，这主要得益于市场对该公司人工心脏瓣膜和其他设备的强劲需求。分析师预计该设备的销售额为 9.742 亿美元，该设备用于对心脏瓣膜疾病患者实施微创手术。爱德华兹公司预计第一季度营收将在15.3亿美元至16.1亿美元之间，预期为15.6亿美元。截至 12 月 31 日的季度收入为 15.3 亿美元，高于分析师平均预期的 15 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edwards.com","stockEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.0835},{"period":"3month","weight":-0.0098},{"period":"6month","weight":0.2711},{"period":"1year","weight":-0.0301},{"period":"ytd","weight":0.118}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"爱德华兹生命科学公司于1999年9月10日在特拉华州注册成立。公司在结构性心脏病以及重症监护和外科监护方面处于全球领先地位。在帮助患者的热情驱使下，公司与世界领先的临床医生和研究人员合作，投资研发，以改变对结构性心脏病患者的护理，或在手术或重症监护期间需要血流动力学监测的患者的护理。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.022412},{"month":2,"riseRate":0.583333,"avgChangeRate":0.013878},{"month":3,"riseRate":0.73913,"avgChangeRate":0.023447},{"month":4,"riseRate":0.625,"avgChangeRate":0.032483},{"month":5,"riseRate":0.72,"avgChangeRate":0.031775},{"month":6,"riseRate":0.666667,"avgChangeRate":0.034877},{"month":7,"riseRate":0.583333,"avgChangeRate":0.016985},{"month":8,"riseRate":0.625,"avgChangeRate":0.013852},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.005417},{"month":10,"riseRate":0.458333,"avgChangeRate":-0.033863},{"month":11,"riseRate":0.666667,"avgChangeRate":0.031108},{"month":12,"riseRate":0.625,"avgChangeRate":0.044933}],"exchange":"NYSE","name":"爱德华兹","nameEN":"Edwards Lifesciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱德华兹(EW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱德华兹(EW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱德华兹,EW,爱德华兹股票,爱德华兹股票老虎,爱德华兹股票老虎国际,爱德华兹行情,爱德华兹股票行情,爱德华兹股价,爱德华兹股市,爱德华兹股票价格,爱德华兹股票交易,爱德华兹股票购买,爱德华兹股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱德华兹(EW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱德华兹(EW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}